CGTX
CGTX
US19243B1026
Cognition Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
24.393.000 34.417.000
29.1%
Operating Income -24.393.000 -34.417.000
29.1%
Pretax Income -23.487.000 -33.971.000
30.9%
Net Income Common Stockholders -23.487.000 -33.971.000
30.9%
-- --
--
-- --
--
ende